Global Partner Acquisition Corp II (NASDAQ:GPAC) & BioLargo (NASDAQ:BLGO) Financial Analysis

Earnings and Valuation

This table compares Global Partner Acquisition Corp II and BioLargo”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global Partner Acquisition Corp II	N/A	N/A	$140,000.00	N/A	N/A
BioLargo	$12.23 million	4.04	-$3.50 million	($0.03)	-5.17

Global Partner Acquisition Corp II has higher earnings, but lower revenue than BioLargo.

Risk and Volatility

Global Partner Acquisition Corp II has a beta of 0.03, suggesting that its share price is 97% less volatile than the S&P 500. Comparatively, BioLargo has a beta of -0.11, suggesting that its share price is 111% less volatile than the S&P 500.

Institutional & Insider Ownership

32.8% of Global Partner Acquisition Corp II shares are owned by institutional investors. Comparatively, 0.0% of BioLargo shares are owned by institutional investors. 65.6% of Global Partner Acquisition Corp II shares are owned by insiders. Comparatively, 20.3% of BioLargo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Global Partner Acquisition Corp II and BioLargo’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Global Partner Acquisition Corp II	N/A	-0.90%	-8.69%
BioLargo	-11.45%	-39.90%	-22.06%

Summary

Global Partner Acquisition Corp II beats BioLargo on 7 of the 8 factors compared between the two stocks.

About Global Partner Acquisition Corp II

Global Partner Acquisition Corp II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Rye Brook, New York.

About BioLargo

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per – and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.